Periprosthetic Joint Infection

Aka: Periprosthetic Joint Infection, Prosthetic Septic Joint, Prosthetic Joint Infection, Infected Joint Replacement

advertisement

II. Risk Factors

  1. Obesity (highest risk)
  2. Cardiac disease
  3. Immunocompromised
  4. Peripheral Vascular Disease
  5. Inflammatory Arthritis
  6. Prior joint infection
  7. Renal disease
  8. Liver disease
  9. Malnutrition
  10. Alcohol Abuse
  11. Tobacco Abuse
  12. Diabetes Mellitus
  13. Anemia
  14. Advanced age (esp. age >80 years old)
  15. Tubb (2020) J Am Acad Orthop Surg 28(8): e340-8 [PubMed]

III. Epidemiology

  1. Prosthetic Joint Infection carries a 1-2% risk at 2 years and >2% at 10 years
  2. Nearly half of infections occur in the first 3 months after surgery (nearly 80% occur within first 2 years)
  3. Prosthetic Hip Joint and Prosthetic Knee Joint infections are responsible for most Prosthetic Septic Joints

IV. Causes

  1. Early infection
    1. Staphylococcus epidermidis
  2. Late Infection
    1. Gram Positive Cocci (e.g. pneumococcus)
    2. Anaerobic Bacteria
    3. Pseudomonas

V. Findings

  1. See Septic Joint
  2. Findings are often more subtle in infected prosthetic joints than in native joint infections
    1. May present with mild Joint Pain and low grade fever
    2. Joint erythema and swelling may be absent

VI. Labs

  1. See Septic Joint
  2. Inflammatory markers (CRP and ESR)
    1. Elevated levels increase suspicion for Septic Joint
  3. Arthrocentesis of prosthetic joint (Aspiration)
    1. Obtain in all suspected cases (and before antibiotics are started)
    2. Ultrasound guided Arthrocentesis facilitates successful procedure
      1. See Knee Arthrocentesis for prosthetic Knee Aspiration technique
    3. Tests
      1. Synovial Fluid Cell Count with differential (esp. Neutrophil percentage)
      2. Synovial FluidGram Stain and culture
      3. Synovial FluidLeukocyte esterase (see diagnosis below)
      4. Synovial FluidLactic Acid (>5.6 mmol/L is positive in prosthetic and native joints)
      5. Synovial Fluid Lactate Dehydrogenase (>250 units/L is positive in prosthetic and native joints)
    4. Findings suggestive of infection differ from native joints
      1. Prosthetic joint WBC Count >1,100/uL (contrast with 3000/uL for native joints)
      2. Prosthetic joint PMN percent >64%
  4. Synovasure Lateral Flow Test
    1. Detects human alpha defensins released by activated Neutrophils
    2. Positive test suggestive of Bacterial periprosthetic infection

VII. Imaging

  1. Nuclear scan
    1. Negative Nuclear scan excludes septic prosthetic joint
  2. Pet Scan
  3. Avoid CT Scan or MRI in infected prosthetic joint
    1. Does not distinguish infected prosthetic joint from other causes of pain

VIII. Diagnosis

  1. Major Criteria
    1. Two joint cultures positive for same organism
    2. Sinus tract communicating with joint
  2. Minor Criteria
    1. Score 2: Serum C-RP > 10 mg/L or D-Dimer > 860 ng/ml
    2. Score 1: Serum ESR >30 mm/hour
    3. Score 3: Synovial WBC >3000/uL or Leukocyte esterase (2+)
    4. Score 3: Synovial Alpha-defensin (signal to cutoff ratio >1)
    5. Score 2: Synovial PMNs >80%
    6. Score 1: Synovial C-RP >6.9 mg/L
  3. Intraoperative Criteria (optional)
    1. Score 3: Histology positive
    2. Score 3: Purulence
    3. Score 2: Single Culture Positive
  4. Interpretation
    1. Infection
      1. Either major criteria positive OR
      2. Minor Criteria Score >6 OR
      3. Minor AND Intraoperative Criteria >6 (with Minor Score at least 2)
    2. Inconclusive
      1. Neither major criteria present AND
      2. Minor AND Intraoperative Criteria 2 to 5 (with Minor Score at least 2)
    3. No Infection
      1. Neither major criteria present AND
      2. Minor Criteria 0 to 1 (or combined with intraoperative criteria <3)
  5. References
    1. Parvizi (2018) J Arthroplasty 33(5): 1309-14 [PubMed]

IX. Management

  1. See Septic Joint
  2. Emergent orthopedic Consultation
    1. Early stage infections may respond to irrigation and Debridement
    2. Late stage infections typically require exchange of Arthrocentesis (e.g. TKA)
  3. Empiric therapy before culture results
    1. Option 1 (2 drug regimen)
      1. Drug 1: Vancomycin
      2. Drug 2: Ciprofloxacin, Aztreonam, or Gentamycin
    2. Option 2 (2 drug regimen)
      1. Drug 1
        1. Ciprofloxacin 750 PO bid or
        2. Ofloxacin 200 mg PO tid
      2. Drug 2: Rifampin 900 mg PO qd
  4. Ciprofloxacin and Rifampin sensitive by culture
    1. Option 1 (2 drug regimen)
      1. Drug 1: Ciprofloxacin or Ofloxacin
      2. Drug 2: Rifampin 900 mg PO qd
    2. Option 2 (2 drug regimen)
      1. Drug 1: Oxacillin 2 grams IV every 4 hours
      2. Drug 2: Rifampin 900 mg PO qd
  5. Ciprofloxacin or Rifampin resistance by culture
    1. Vancomycin and
    2. Rifampin (if sensitive)

X. References

  1. Buddendorff (2021) Crit Dec Emerg Med 35(12): 18-9
  2. Voorhees and Riveros (2024) Crit Dec Emerg Med 38(3):22-3
  3. Earwood (2021) Am Fam Physician 104(6): 589-97 [PubMed]

Images: Related links to external sites (from Bing)

These images are a random sampling from a Bing search on the term "Periprosthetic Joint Infection." Click on the image (or right click) to open the source website in a new browser window. Search Bing for all related images

Related Studies

Related Topics in Infectious Disease

advertisement